Blog

Amylyx will get ‘back on (its) feet’ after ALS trial fail, says co-CEO

dsc0005-orig-brightened900xx2730-1820-0-51

From the outside, the future of Amylyx Pharmaceuticals Inc. may look uncertain. But the company’s co-CEOs aren’t losing hope.

Read More